1. Home
  2. GDTC vs VHC Comparison

GDTC vs VHC Comparison

Compare GDTC & VHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • VHC
  • Stock Information
  • Founded
  • GDTC 2018
  • VHC 2005
  • Country
  • GDTC Singapore
  • VHC United States
  • Employees
  • GDTC N/A
  • VHC N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • VHC Multi-Sector Companies
  • Sector
  • GDTC Health Care
  • VHC Miscellaneous
  • Exchange
  • GDTC Nasdaq
  • VHC Nasdaq
  • Market Cap
  • GDTC 23.7M
  • VHC 26.2M
  • IPO Year
  • GDTC 2023
  • VHC 1999
  • Fundamental
  • Price
  • GDTC $2.13
  • VHC $6.45
  • Analyst Decision
  • GDTC Buy
  • VHC
  • Analyst Count
  • GDTC 1
  • VHC 0
  • Target Price
  • GDTC $5.00
  • VHC N/A
  • AVG Volume (30 Days)
  • GDTC 12.4K
  • VHC 9.2K
  • Earning Date
  • GDTC 01-01-0001
  • VHC 11-07-2024
  • Dividend Yield
  • GDTC N/A
  • VHC N/A
  • EPS Growth
  • GDTC N/A
  • VHC N/A
  • EPS
  • GDTC N/A
  • VHC N/A
  • Revenue
  • GDTC $330,254.00
  • VHC $6,000.00
  • Revenue This Year
  • GDTC $4.46
  • VHC N/A
  • Revenue Next Year
  • GDTC N/A
  • VHC N/A
  • P/E Ratio
  • GDTC N/A
  • VHC N/A
  • Revenue Growth
  • GDTC N/A
  • VHC N/A
  • 52 Week Low
  • GDTC $1.20
  • VHC $3.50
  • 52 Week High
  • GDTC $5.50
  • VHC $9.44
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 69.51
  • VHC 34.11
  • Support Level
  • GDTC $1.96
  • VHC $6.54
  • Resistance Level
  • GDTC $2.16
  • VHC $7.22
  • Average True Range (ATR)
  • GDTC 0.15
  • VHC 0.22
  • MACD
  • GDTC 0.03
  • VHC -0.07
  • Stochastic Oscillator
  • GDTC 84.07
  • VHC 0.00

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services, and critical infrastructures.

Share on Social Networks: